OCTOCAINE Drug Patent Profile
Which patents cover Octocaine, and when can generic versions of Octocaine launch?
Octocaine is a drug marketed by Septodont and is included in one NDA.
The generic ingredient in OCTOCAINE is epinephrine; lidocaine hydrochloride. There is one drug master file entry for this compound. Twelve suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for OCTOCAINE?
- What are the global sales for OCTOCAINE?
- What is Average Wholesale Price for OCTOCAINE?
Summary for OCTOCAINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 112 |
| Clinical Trials: | 3 |
| DailyMed Link: | OCTOCAINE at DailyMed |
Recent Clinical Trials for OCTOCAINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Riyadh Elm University | Phase 4 |
| National Taiwan University Hospital | N/A |
| King Abdulaziz University | Phase 4 |
US Patents and Regulatory Information for OCTOCAINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septodont | OCTOCAINE | epinephrine; lidocaine hydrochloride | INJECTABLE;INJECTION | 084048-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Septodont | OCTOCAINE | epinephrine; lidocaine hydrochloride | INJECTABLE;INJECTION | 084048-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
